BIOMAT Database Logo BIOMAT Database Logo

Blockade of thromboxane/endoperoxide receptor-mediated responses in the pulmonary vascular bed of the cat by sulotroban. 1992

B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Department of Anesthesiology, Tulane University School of Medicine, New Orleans, LA 70112.

The effects of sulotroban (BM13.177; SK & F 95587), a thromboxane (TX) A2/endoperoxide (PGH2) receptor blocking agent on responses to the TXA2/PGH2 mimics, U46619 and U44069, were investigated in the pulmonary vascular bed of the intact-chest cat under constant flow conditions. Injections of U46619 and U44069 directly into the perfused lobar artery caused dose-related increases in lobar arterial pressure without altering left atrial pressure. Following administration of sulotroban in a dose of 5 mg/kg i.v., dose-response curves for U46619 and U44069 were shifted to the right in a parallel manner. The duration of the blocking effect of sulotroban was investigated, and responses to U46619 returned to approximately 50% of control in 120 min and were not significantly different from control 240 min after administration of the receptor antagonist. Sulotroban was without significant effect on responses to prostaglandin (PG) D2 or F2 alpha or serotonin, histamine, norepinephrine, angiotensin II or BAY K8644, an agent which enhances calcium entry. Sulotroban was without effect on responses to endothelin (ET)-1, sarafotoxin (S) 6a or S6c and platelet-activating factor (PAF). Sulotroban did not alter baseline vascular pressures in the cat and responses to the PG and TXA2/PGH2 precursor, arachidonic acid, were reduced. The present data show that sulotroban selectively blocks TXA2/PGH2 receptor-mediated responses in a competitive and reversible manner in the pulmonary vascular bed.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D011450 Prostaglandin Endoperoxides, Synthetic Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. Prostaglandin Endoperoxide Analogs,Prostaglandin Endoperoxide Analogues,Synthetic Prostaglandin Endoperoxides,Analogues, Prostaglandin Endoperoxide,Endoperoxide Analogues, Prostaglandin,Endoperoxides, Synthetic Prostaglandin
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D005260 Female Females

Related Publications

B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Sulotroban selectively inhibits thromboxane-receptor-mediated responses in the peripheral vascular bed of the cat.
January 1992, Eicosanoids,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Analysis of thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
January 1995, Critical care medicine,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Foetal vascular responses to thromboxane receptor blockade.
January 1992, Mediators of inflammation,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Analysis of gamma-aminobutyric acid-mediated responses in the pulmonary vascular bed of the cat.
September 2004, Anesthesia and analgesia,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
February 1986, The Journal of clinical investigation,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
January 2004, Vascular pharmacology,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Nisoldipine inhibits vasoconstrictor responses in the cat pulmonary vascular bed.
June 1989, Journal of applied physiology (Bethesda, Md. : 1985),
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Analysis of ketamine responses in the pulmonary vascular bed of the cat.
April 2000, Critical care medicine,
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Blockade of thromboxane responses in the airway of the cat by SQ 29,548.
June 1987, Journal of applied physiology (Bethesda, Md. : 1985),
B D Nossaman, and T J McMahon, and M S Ragheb, and I N Ibrahim, and C R Babycos, and J S Hood, and P J Kadowitz
Analysis of responses to pentoxifylline in the pulmonary vascular bed of the cat.
February 1996, Critical care medicine,
Copied contents to your clipboard!